Sicene and technology company Merck is to acquire Chord Therapeutics (Chord), a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, launched in October 2020 by leadng healthcare venture capital firm Omega Funds, the sole investor in the Company’s USD 16 million Series A financing. The strategic acquisition enables
Valeas Capital Partners, a recently launched investor-operator focused firm led by Ed Woiteshek and Rob Little (former Hellman & Friedman colleagues) has led a USD70 million Series B equity financing round in Well Dot (Well), a consumer-focused health improvement platform that combines leading-edge artificial intelligence, advanced behavioural economic techniques and
Singular has led a EUR30 million Series A fuding round in Formel Skin, a healthtech startup. The funding will be used to expand the healthcare platform to new markets and launch additional medical treatments, as part of its mission to offer individualised, high-quality medical treatments online. Other investors in the
Maven Capital Partners (Maven) has exited its investment in Westfield Medical Group Limited (Westfield) via a trade sale to France domiciled Sterimed Group which generated a 2.2x blended return for investors. UK-based Westfield is a provider of single use sterilisation barrier packaging and other sterilisation products to the public and
Kartesia, a European provider of capital solutions for small and mid-sized companies, has provided a loan facility to support The Rohatyn Group (TRG) and the Founders of Optimapharm in the refinancing and growth financing of the Company. The Rohatyn Group is a global asset management firm with expertise in emerging
nThrive, a healthcare revenue cycle management (RCM) software-as-a-service (SaaS) platform provider, backed by Clearlake Capital Group, has completed the acquisition of TransUnion Healthcare, the healthcare data and analytics business of TransUnion. The unified business will offer healthcare organisations one of the most complete end-to-end RCM technology solutions available, streamlining patient
Stone-Goff Partners has exited its investment in Danforth Advisors (Danforth) following a private equity investment in the company by Avesi Partners, LLC. Drawn to the company’s deep experience base and focus on the growing life sciences end market, Stone-Goff Partners invested in Danforth in 2018, alongside its founding partners. Based
Funds advised by SK Capital Partners (SK Capital), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has acquire a majority shareholding in SEQENS, a pharmaceutical solutions and specialty ingredients companies. SK Capital is investing alongside several other investors including Bpifrance, the French national investment bank,
Great Point Partners (GPP), a Greenwich-based private investment firm focused exclusively on the health care industry, has sold Softbox Systems (Softbox) to to CSafe Global, a portfolio company of Frazier Healthcare Partners and Thomas H Lee Partners. UK-based Softbox is a provider of passive temperature-controlled packaging solutions for the pharmaceutical,
Existing investors Boehringer Ingelheim Venture Fund (BIVF) and Parkwalk Advisors have lead a GBP16 million Series B funding round in Brainomix, an AI-powered medtech solutions company. New investor, Tencent Holdings, also participated in the round along with the Oxford University Innovation Fund (OUIF), with the investment set to be used
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
